ADHD is the one of the most common neurodevelopmental disorder in children and adolescents which will most likely persist into adulthood. Hence, early identification and implementation of effective treatments are vital. Available pharmacological treatment options for ADHD demonstrate overall good short-term drug effects and tolerability. Ongoing efforts to expand possibilities for people with ADHD are of the utmost importance. Currently, several novel medications are in development in the hope of improving cognitive function, quality of life and overall therapeutic outcomes.